Biogen - BIIB Company Short-Term Debt

Public company logo of Biogen (BIIB)

Biogen's stable income is ensured by patient dependence on therapies for rare diseases, while the shortfall in its own developments is compensated for by acquiring external licenses. The short-term debt chart shows the dynamics of current credit obligations, with the figure stabilizing at 1.37. The brand's high reputation in medicine is confirmed by its bold Alzheimer's research and the development of innovative brain treatments.

BIIB biogen.com Company Short-Term Debt (07/04/2022 - 10/28/2026)

Summary analytical data breakdowns for Biogen Idec (BIIB)

- price and consensus price forecast:
Price Chart Biogen|BIIB - Fair Value Consensus
- market capitalization data:
Market Value Biogen Inc.|BIIB - Total Enterprise Value
- book capitalization data:
Book Value per Share Biogen|BIIB - Company Book Value|Market Capitalization to Book Value Ratio biogen.com|BIIB - Company Total Asset Base
- debt and liquidity data:
Debt to Equity Biogen Inc.|BIIB - Long-Term Liabilities to Capital|Short-Term Debt to Capital Biogen Inc.|BIIB - Company Total Indebtedness|Debts to Book Capitalization Biogen Inc.|BIIB - Long-Term Debt|Company Short-Term Debt Biogen
Analysis of all company metrics:Biogen, BIIB
Finished products of Biogen Idec

The indicator's dynamics depend directly on the balance between operating cash flows and current liabilities. This metric aggregates all debts due within twelve months to measure business liquidity. For Biogen Inc. (BIIB), this is critical when funding R&D and launching Leqembi into the market amid declining revenues from legacy drugs. An increase in short-term accounts payable signals a risk of capital deficiency. Analyze this short-term debt load to assess the sustainability of the restructuring.

Competitor analysis for Biogen Inc.

Company Short-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Short-Term Loans and Borrowings|Company Short-Term Debt AXSM|ACADIA Corp (ACAD) - Short-Term Debt|Company Short-Term Debts Xenon Pharmaceuticals|Company Short-Term Debt vikingtherapeutics.com|SUPN (Supernus) - Company Short-Term Debts|Short-Term Debt Volume CPRX (Catalyst Pharma)|DNLI: Company Short-Term Debt|Short-Term Debt Harmony Corp HRMY|Company Short-Term Debts BHVN|AMLX - Short-Term Indebtedness|Company Short-Term Debts TRVI|PRAX (Praxis Precision Medicines Inc) - Short-Term Debt|Company Short-Term Debt Anavex Corp (AVXL)|Company Short-Term Indebtedness CeriBell EEG (CBLL)|Prothena (PRTA) - Company Current Liabilities|Company Short-Term Loans and Borrowings alector.com (ALEC)|Company Short-Term Debts ANNX|Omeros Corp - Short-Term Debt Volume|Neurogene Corp (NGNE) - Company Short-Term Debt|ACIU - Company Short-Term Indebtedness|VYGR (Voyager Therapeutics) - Company Short-Term Debts|Company Current Liabilities neumoratx.com|SCLX: Company Current Liabilities|Short-Term Debt Volume Tevogen Bio Holdings Inc.|Company Short-Term Debts Alpha Cognition (ACOG)|Company Short-Term Debt cogrx.com (CGTX)|Company Short-Term Debts IKT|Short-Term Debt Volume cassavasciences.com SAVA|Company Short-Term Debts ASRT (Assertio Therapeutics)|COYA - Short-Term Debt Volume|vistagen.com (VTGN) - Company Short-Term Debts|OVID (Ovid Therapeutics) - Company Short-Term Debt|Company Short-Term Debt Acumen Pharmaceuticals (ABOS)|Company Short-Term Indebtedness cervomed.com|Alterity Therapeutics - Company Short-Term Debts|Short-Term Debt clene.com CLNN|Company Current Liabilities PEPG (PepGen)|jupiterneurosciences.com - Company Short-Term Debts|Company Short-Term Debt Relmada Therapeutics (RLMD)|ANVS: Company Short-Term Loans and Borrowings|Company Short-Term Debt GRCE|Firefly Neuroscience, Inc. (AIFF) - Short-Term Debt|Company Short-Term Debts ANEW Medical|Company Short-Term Debt NeuroSense Therapeutics, Ltd.|RVPH (Reviva Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt Volume MTVA (metaviatx.com)|NRXS: Company Short-Term Debt|Short-Term Debt Helius Medical Technologies, Inc. HSDT|Company Short-Term Debts PASG|NEUP - Short-Term Indebtedness|Company Short-Term Debts NERV|ATHA (athira.com) - Short-Term Debt|Company Short-Term Debt Addex Therapeutics Ltd (ADXN)|Company Short-Term Indebtedness Alzamend (ALZN)|Cyclerion Therapeutics (CYCN) - Company Current Liabilities|Company Short-Term Loans and Borrowings protagenic.com (PTIX)|Company Short-Term Debts KTTA|Cortigent Inc - Short-Term Debt Volume|Avenue Therapeutics, Inc. (ATXI) - Company Short-Term Debt|BCLI - Company Short-Term Indebtedness|CARA (Cara Therapeutics, Inc) - Company Short-Term Debts|Company Current Liabilities Chromocell|ELYM: Company Current Liabilities|Short-Term Debt Volume Intra-Cellular|Company Short-Term Debts Longboard Pharmaceuticals, Inc. (LBPH)|Company Short-Term Debt Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debts NKGN|Short-Term Debt Volume NeuroBo Pharma NRBO|Company Short-Term Debts SAGE (Sage Therapeutics, Inc.)|SNPX - Short-Term Debt Volume|Trevena (TRVN) - Company Short-Term Debts|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debt|Company Short-Term Debt Anew Medical, Inc. (WENA)|Company Short-Term Indebtedness Cerevel Corp